Skip to main navigation Skip to search Skip to main content

A victim of its own progress: why the success of modern therapeutics forces a re-evaluation of placebo-controlled trials in migraine prevention

  • Nirit Lev
  • , Leah Borovoi
  • , Emily Elefant
  • , Erel Domany
  • , Oved Daniel
  • , Gal Ifergane

Research output: Contribution to journalComment/debate

Original languageEnglish
Article number1871028
JournalFrontiers in Neurology
Volume17
DOIs
StatePublished - 1 Apr 2026

Keywords

  • calcitonin gene-related peptide (CGRP)
  • clinical trial design
  • declaration of Helsinki
  • migraine
  • neuroethics
  • placebo
  • placebo-controlled trials

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this